H. pylori enzymes

The term "H. pylori enzymes" refers to a broad category of enzymatic proteins produced by the bacterium *Helicobacter pylori*, rather than to a single, specific molecular target. This term encompasses a diverse set of enzymes involved in colonization, pathogenesis, metabolic survival, and adaptation of *H. pylori* within the human gastric environment[3][4]. As such, addressing this as a single molecular target is **imprecise** and does not conform to the convention of identifying specific therapeutic targets. “H. pylori enzymes” is a non-specific term that refers collectively to the suite of enzymes produced by the bacterium *Helicobacter pylori*. These include well-characterized enzymes such as urease (crucial for gastric colonization through urea hydrolysis and pH neutralization), catalase, superoxide dismutase (defense against reactive oxygen species), alcohol dehydrogenase, phospholipases, proteases, type II restriction endonucleases, autolysins, and metabolic enzymes involved in amino acid and nucleotide biosynthesis[3][2][1][4][5]. These enzymes serve a broad range of functions including enabling initial colonization, protecting against the host immune response, facilitating nutrient acquisition, and contributing to gastric mucosal injury. Some, such as urease, are directly targeted for diagnostic and therapeutic purposes. However, because “H. pylori enzymes” does not name a unique or primary molecular target, it is not considered a standard therapeutic target designation[3][4].

Other names

Helicobacter pylori enzymesEnzymes of H. pylori

Inhibition of enzymatic activity required for survival or colonization (e.g., urease inhibitors reduce gastric survival)